Accenture plc (NYSE:ACN) should attract all Enterprising Investors, particularly due to the company's stable earnings growth over the last few years. That said, Benjamin Graham, the father of value investing, taught that the most important aspect to consider is whether the company is trading at a discount relative to its intrinsic value. It is through a thorough fundamental analysis that the investor is able to make a determination about a potential investment's merits. Here is a look at how Accenture plc fares in the ModernGraham valuation model.
The model is inspired by the teachings of Benjamin Graham and considers numerous metrics intended to help the investor reduce risk levels. The first part of the analysis is to determine whether the company is suitable for the very conservative Defensive Investor or the less conservative Enterprising Investor, who is willing to spend a greater amount of time conducting further research.
In addition, Graham strongly suggested that investors avoid speculation in order to remove the subjective elements of emotion. This is best achieved by utilizing a systematic approach to analysis that will provide investors with a sense of how a specific company compares to another company. By using the ModernGraham method, one can review a company's historical accomplishments and determine an intrinsic value that can be compared across industries.
Defensive Investor - must pass at least 6 of the following 7 tests: Score = 4/7
Enterprising Investor - must pass at least 4 of the following 5 tests or be suitable for a defensive investor: Score = 4/5
Valuation Summary
Key Data:
Recent Price | $85.18 |
MG Value | $89.34 |
MG Opinion | Fairly Valued |
Value Based on 3% Growth | $61.17 |
Value Based on 0% Growth | $35.86 |
Market-Implied Growth Rate | 5.85% |
NCAV | -$0.43 |
PEmg | 20.19 |
Current Ratio | 1.46 |
PB Ratio | 10.22 |
Balance Sheet - September 2014
Current Assets | $11,904,000,000 |
Current Liabilities | $8,158,000,000 |
Total Debt | $26,500,000 |
Total Assets | $17,930,000,000 |
Intangible Assets | $2,396,000,000 |
Total Liabilities | $12,198,000,000 |
Outstanding Shares | 687,700,000 |
Earnings Per Share
2014 | $4.52 |
2013 | $4.93 |
2012 | $3.84 |
2011 | $3.39 |
2010 | $2.66 |
2009 | $2.44 |
2008 | $2.65 |
2007 | $1.97 |
2006 | $1.59 |
2005 | $1.56 |
2004 | $0.69 |
Earnings Per Share - ModernGraham
2014 | $4.22 |
2013 | $3.86 |
2012 | $3.22 |
2011 | $2.81 |
2010 | $2.44 |
2009 | $2.23 |
Dividend History
ACN Dividend data by YCharts
Conclusion:
Accenture should satisfy the Enterprising Investor, but not the Defensive Investor. The Defensive Investor is concerned with the low current ratio as well as the high PEmg and PB ratios, while the Enterprising Investor is only concerned initially by the low current ratio. Therefore, Enterprising Investors should feel very comfortable proceeding to the next part of the analysis, which is a determination of the company's intrinsic value.
From a valuation side of things, the company has grown its EPSmg (normalized earnings) from $2.44 in 2010 to $4.22 for 2014. This is very strong and an impressive level of demonstrated growth which is in line with the market's implied estimate for earnings growth of 5.85% over the next 7-10 years. In fact, actual historical growth is about 8.45% per year, so the market has priced in a slight earnings drop to a more sustainable level over the long term. The ModernGraham valuation model therefore returns an estimate of intrinsic value falling within a margin of safety relative to the current price, indicating the company is fairly valued at the present time.
Be sure to check out previous ModernGraham valuations of Accenture plc for more perspective!
This article was written by
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.